Stock Code: 1720 Company Name: Shengda Industry: Biotechnology and Healthcare Reporting Month: June 2026 Monthly Revenue: NT$615,012 thousand (NT$615.012 million) Year-on-Year Change: +9.1%
Keywords: Monthly Revenue, Biotechnology and Healthcare Industry
Shengda has released its monthly revenue report for June 2026. The company achieved revenue of NT$615,012 thousand (approximately NT$615.012 million), marking a 9.1% increase compared to the same month last year. This growth indicates continued demand expansion and successful portfolio enhancement within the biotechnology and healthcare industry. Shengda remains committed to advancing pharmaceutical R&D and optimizing supply chains to sustain stable business growth in the future.
FACT BOX
- Source: PR Times
- Category: News